CXCR4 and cancer: Given that identical cancer cells were injected into all animals, these results indicated that the microenvironments diverged quickly between WT and TgMISIIR-TAg-Low mice and impacted the ability to generate antitumor immunity after OV-CXCR4-A treatment through immune modulation.